Published on Monday April 15, 2013
Smooth Drug Development successfully passed a financial audit
Smooth Drug Development successfully passed a financial audit of the Ministry of Education of the Russian Federation.
"The main goal of Smooth Drug Development is to contribute to protection of public health, participating in development of affordable and effective medicines. Our priority is development of modern drugs that meet requirements of the healthcare system and expectations of doctors and patients."
Dmitry Morozovsky, MD, EMBA, CEO, managing partner
Smooth Drug Development provides full spectrum CRO services in Russia, CIS and Baltic states since 2011.